English

Hepion Pharmaceuticals, Inc.

EDGAR

CTRVP Quarterly report (10-Q) · filed 2026-08-13

79 filing records in this dataset, filed from 2013-11-19 to 2026-08-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2024 Q1 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-3.62 million USD

2024 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -3616793 USD Source

Cash and cash equivalents: 13.9 million Unit12 2019-12-31 Source
Exact value

13922972 Unit12
Long-term debt including current maturities: Not available
Shares outstanding: 29.1 million shares 2026-06-30 Source
Exact value

29120317 shares

Reported share-count change

150.60% · 17.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

11620317 shares · 2025-06-30· Source
29120317 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2023-04-01 – 2024-03-31

Exact inputs and evidence

Revenue: 0 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 0 USD · 2023-07-01 – 2023-09-30 Source
Revenue: 0 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 0 USD · 2023-01-01 – 2023-09-30 Source
Revenue: 0 USD · 2024-01-01 – 2024-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2023-12-31
Operating income: 6 of 11 periods available· newest 2025-12-31
Net income: 6 of 11 periods available· newest 2025-12-31
Operating cash flow: 6 of 11 periods available· newest 2025-12-31
Capital expenditure: 4 of 11 periods available· newest 2023-12-31
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2019-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 4.91 million

Prior period

−USD 13.19 million

2024-01-01 – 2024-12-31
Current period

−USD 8.28 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-8277850 − -13192420 = 4914570 USD

-13192420 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-8277850 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Hepion Pharmaceuticals, Inc. · 2025-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Year-over-year change in Net income: 4914570 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -8277850 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000149315226009755/form10-k.htm#1417287 Filing: 000149315226009755 Input fundies:NetIncome: -13192420 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000149315226009755/form10-k.htm#1417771 Filing: 000149315226009755
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 14.92 million

Prior period

−USD 18.22 million

2024-01-01 – 2024-12-31
Current period

−USD 3.3 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-3300000 − -18216303 = 14916303 USD

-18216303 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-3300000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Hepion Pharmaceuticals, Inc. · 2025-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Year-over-year change in Operating cash flow: 14916303 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -3300000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000149315226009755/form10-k.htm#1065404 Filing: 000149315226009755 Input fundies:OperatingCashFlow: -18216303 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000149315226009755/form10-k.htm#1016849 Filing: 000149315226009755
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 0
Operating costs Derived USD 48.45 million
Operating income −USD 48.45 million
Tax, interest and other Derived USD 478,088
Net income −USD 48.93 million

Cash

Operating cash flow −USD 40.89 million
Capital expenditure USD 14,304
Free cash flow Derived −USD 40.9 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Not shown: operating income or net income is not reported.
2021 Not shown: operating income or net income is not reported.
2022 Not shown: operating income or net income is not reported.
2023 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	20146075 Derived	-20146075	207863 Derived	-20353938	-16253185 Derived	Source 2020-01-01 – 2020-12-31: 0 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -20146075 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -20353938 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -16165202 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 87983 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	30403309 Derived	-30403309	2318859 Derived	-32722168	-31354886 Derived	Source 2021-01-01 – 2021-12-31: 0 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -30403309 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -32722168 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -31224481 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 130405 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	45488726 Derived	-45488726	-3288677 Derived	-42200049	-34977507 Derived	Source 2022-01-01 – 2022-12-31: 0 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -45488726 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -42200049 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -34961171 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 16336 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	48447954 Derived	-48447954	478088 Derived	-48926042	-40903182 Derived	Source 2023-01-01 – 2023-12-31: 0 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -48447954 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -48926042 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -40888878 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 14304 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2023

Values and sources

Revenue values and source evidence
Period	Series	Source evidence
20202020-12-31	Revenue	Revenue: 0 Open source
20212021-12-31	Revenue	Revenue: 0 Open source
20222022-12-31	Revenue	Revenue: 0 Open source
20232023-12-31	Revenue	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20212021-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20222022-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20232023-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	Not reported	Operating Income: -20146075 Open source Revenue: 0 Open source
20212021-12-31	Operating margin	Not reported	Operating Income: -30403309 Open source Revenue: 0 Open source
20222022-12-31	Operating margin	Not reported	Operating Income: -45488726 Open source Revenue: 0 Open source
20232023-12-31	Operating margin	Not reported	Operating Income: -48447954 Open source Revenue: 0 Open source
20202020-12-31	Net margin	Not reported	Net Income: -20353938 Open source Revenue: 0 Open source
20212021-12-31	Net margin	Not reported	Net Income: -32722168 Open source Revenue: 0 Open source
20222022-12-31	Net margin	Not reported	Net Income: -42200049 Open source Revenue: 0 Open source
20232023-12-31	Net margin	Not reported	Net Income: -48926042 Open source Revenue: 0 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -16165202 Open source Capital Expenditure: 87983 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -31224481 Open source Capital Expenditure: 130405 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -34961171 Open source Capital Expenditure: 16336 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -40888878 Open source Capital Expenditure: 14304 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -40.9M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	-16165202	Operating Cash Flow: -16165202 Open source
20212021-12-31	Operating cash flow	-31224481	Operating Cash Flow: -31224481 Open source
20222022-12-31	Operating cash flow	-34961171	Operating Cash Flow: -34961171 Open source
20232023-12-31	Operating cash flow	-40888878	Operating Cash Flow: -40888878 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -40.9M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	-16253185	Operating Cash Flow: -16165202 Open source Capital Expenditure: 87983 Open source
20212021-12-31	Free cash flow	-31354886	Operating Cash Flow: -31224481 Open source Capital Expenditure: 130405 Open source
20222022-12-31	Free cash flow	-34977507	Operating Cash Flow: -34961171 Open source Capital Expenditure: 16336 Open source
20232023-12-31	Free cash flow	-40903182	Operating Cash Flow: -40888878 Open source Capital Expenditure: 14304 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

59.8% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	16.7%	Total Liabilities: 8124862 Open source Total Assets: 48645253 Open source
20212021-12-31	Liabilities / assets	10.2%	Total Liabilities: 10557476 Open source Total Assets: 103552479 Open source
20222022-12-31	Liabilities / assets	17.2%	Total Liabilities: 10388515 Open source Total Assets: 60244452 Open source
20232023-12-31	Liabilities / assets	59.8%	Total Liabilities: 10813590 Open source Total Assets: 18094397 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.31× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	9.15×	Current Assets: 42634299 Open source Current Liabilities: 4661827 Open source
20212021-12-31	Current assets / current liabilities	11.88×	Current Assets: 97451768 Open source Current Liabilities: 8206396 Open source
20222022-12-31	Current assets / current liabilities	7.16×	Current Assets: 56496073 Open source Current Liabilities: 7885722 Open source
20232023-12-31	Current assets / current liabilities	3.31×	Current Assets: 17487840 Open source Current Liabilities: 5290096 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 20.35 million Exact value Exact value: -20353938 USD 2020-01-01 – 2020-12-31: -20353938 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hepion Pharmaceuticals, Inc. · 2020-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Net Income: -20353938 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20353938 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377122000003/hepa-20211231.htm#1563698 Filing: 000158377122000003 The citation records this snapshot. The page link may show a newer release later.	−USD 16.17 million Exact value Exact value: -16165202 USD 2020-01-01 – 2020-12-31: -16165202 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hepion Pharmaceuticals, Inc. · 2020-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Operating Cash Flow: -16165202 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16165202 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377122000003/hepa-20211231.htm#953079 Filing: 000158377122000003 The citation records this snapshot. The page link may show a newer release later.	USD 87,983 Exact value Exact value: 87983 USD 2020-01-01 – 2020-12-31: 87983 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Hepion Pharmaceuticals, Inc. · 2020-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Capital Expenditure: 87983 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 87983 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377122000003/hepa-20211231.htm#956155 Filing: 000158377122000003 The citation records this snapshot. The page link may show a newer release later.	−USD 16.25 million Calculation and evidence -16165202 − 87983 USD Exact free cash flow: -16253185 USD 2020-01-01 – 2020-12-31: -16165202 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 87983 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Hepion Pharmaceuticals, Inc. · 2020-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Free cash flow: -16253185 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16165202 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377122000003/hepa-20211231.htm#953079 Filing: 000158377122000003 Input fundies:CapitalExpenditure: 87983 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377122000003/hepa-20211231.htm#956155 Filing: 000158377122000003 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 32.72 million Exact value Exact value: -32722168 USD 2021-01-01 – 2021-12-31: -32722168 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hepion Pharmaceuticals, Inc. · 2021-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Net Income: -32722168 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32722168 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377123000003/hepa-20221231.htm#1384275 Filing: 000158377123000003 The citation records this snapshot. The page link may show a newer release later.	−USD 31.22 million Exact value Exact value: -31224481 USD 2021-01-01 – 2021-12-31: -31224481 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hepion Pharmaceuticals, Inc. · 2021-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Operating Cash Flow: -31224481 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31224481 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377123000003/hepa-20221231.htm#980417 Filing: 000158377123000003 The citation records this snapshot. The page link may show a newer release later.	USD 130,405 Exact value Exact value: 130405 USD 2021-01-01 – 2021-12-31: 130405 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Hepion Pharmaceuticals, Inc. · 2021-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Capital Expenditure: 130405 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 130405 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377123000003/hepa-20221231.htm#982820 Filing: 000158377123000003 The citation records this snapshot. The page link may show a newer release later.	−USD 31.35 million Calculation and evidence -31224481 − 130405 USD Exact free cash flow: -31354886 USD 2021-01-01 – 2021-12-31: -31224481 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 130405 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Hepion Pharmaceuticals, Inc. · 2021-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Free cash flow: -31354886 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31224481 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377123000003/hepa-20221231.htm#980417 Filing: 000158377123000003 Input fundies:CapitalExpenditure: 130405 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377123000003/hepa-20221231.htm#982820 Filing: 000158377123000003 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 42.2 million Exact value Exact value: -42200049 USD 2022-01-01 – 2022-12-31: -42200049 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hepion Pharmaceuticals, Inc. · 2022-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Net Income: -42200049 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42200049 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377124000003/hepa-20231231.htm#1226983 Filing: 000158377124000003 The citation records this snapshot. The page link may show a newer release later.	−USD 34.96 million Exact value Exact value: -34961171 USD 2022-01-01 – 2022-12-31: -34961171 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hepion Pharmaceuticals, Inc. · 2022-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Operating Cash Flow: -34961171 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -34961171 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377124000003/hepa-20231231.htm#862997 Filing: 000158377124000003 The citation records this snapshot. The page link may show a newer release later.	USD 16,336 Exact value Exact value: 16336 USD 2022-01-01 – 2022-12-31: 16336 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Hepion Pharmaceuticals, Inc. · 2022-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Capital Expenditure: 16336 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16336 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377124000003/hepa-20231231.htm#865263 Filing: 000158377124000003 The citation records this snapshot. The page link may show a newer release later.	−USD 34.98 million Calculation and evidence -34961171 − 16336 USD Exact free cash flow: -34977507 USD 2022-01-01 – 2022-12-31: -34961171 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 16336 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Hepion Pharmaceuticals, Inc. · 2022-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Free cash flow: -34977507 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -34961171 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377124000003/hepa-20231231.htm#862997 Filing: 000158377124000003 Input fundies:CapitalExpenditure: 16336 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000158377124000003/hepa-20231231.htm#865263 Filing: 000158377124000003 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 48.93 million Exact value Exact value: -48926042 USD 2023-01-01 – 2023-12-31: -48926042 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hepion Pharmaceuticals, Inc. · 2023-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Net Income: -48926042 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -48926042 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000164117225003250/form10-k.htm#1621855 Filing: 000164117225003250 The citation records this snapshot. The page link may show a newer release later.	−USD 40.89 million Exact value Exact value: -40888878 USD 2023-01-01 – 2023-12-31: -40888878 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hepion Pharmaceuticals, Inc. · 2023-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Operating Cash Flow: -40888878 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40888878 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000164117225003250/form10-k.htm#1138215 Filing: 000164117225003250 The citation records this snapshot. The page link may show a newer release later.	USD 14,304 Exact value Exact value: 14304 USD 2023-01-01 – 2023-12-31: 14304 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Hepion Pharmaceuticals, Inc. · 2023-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Capital Expenditure: 14304 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14304 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000164117225003250/form10-k.htm#1141673 Filing: 000164117225003250 The citation records this snapshot. The page link may show a newer release later.	−USD 40.9 million Calculation and evidence -40888878 − 14304 USD Exact free cash flow: -40903182 USD 2023-01-01 – 2023-12-31: -40888878 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 14304 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Hepion Pharmaceuticals, Inc. · 2023-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Free cash flow: -40903182 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40888878 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000164117225003250/form10-k.htm#1138215 Filing: 000164117225003250 Input fundies:CapitalExpenditure: 14304 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000164117225003250/form10-k.htm#1141673 Filing: 000164117225003250 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 13.19 million Exact value Exact value: -13192420 USD 2024-01-01 – 2024-12-31: -13192420 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hepion Pharmaceuticals, Inc. · 2024-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Net Income: -13192420 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13192420 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000149315226009755/form10-k.htm#1417771 Filing: 000149315226009755 The citation records this snapshot. The page link may show a newer release later.	−USD 18.22 million Exact value Exact value: -18216303 USD 2024-01-01 – 2024-12-31: -18216303 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hepion Pharmaceuticals, Inc. · 2024-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Operating Cash Flow: -18216303 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18216303 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000149315226009755/form10-k.htm#1016849 Filing: 000149315226009755 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2025-01-01 – 2025-12-31	−USD 8.28 million Exact value Exact value: -8277850 USD 2025-01-01 – 2025-12-31: -8277850 USD Inspect Net Income Open source Share or cite Citation for Net Income · Hepion Pharmaceuticals, Inc. · 2025-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Net Income: -8277850 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8277850 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000149315226009755/form10-k.htm#1417287 Filing: 000149315226009755 The citation records this snapshot. The page link may show a newer release later.	−USD 3.3 million Exact value Exact value: -3300000 USD 2025-01-01 – 2025-12-31: -3300000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Hepion Pharmaceuticals, Inc. · 2025-12-31 Hepion Pharmaceuticals, Inc. (edgar:1583771) Operating Cash Flow: -3300000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1583771/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3300000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1583771/000149315226009755/form10-k.htm#1065404 Filing: 000149315226009755 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

79 filings · 2,761 latest values · 2,761 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001583771, 1583771, CTRVP, HEPA, edgar:1583771

Also known as ContraVir Pharmaceuticals, Inc., HEPION PHARMACEUTICALS, INC., HEPION PHARMACEUTICALS, INC., Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation